12001-79-5
基本信息
Synkavite
VITAMIN K
VITAMIN K1 USP23
Vitamin K substances
2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
物理化學(xué)性質(zhì)
應(yīng)用領(lǐng)域
安全數(shù)據(jù)
常見問題列表
維生素K是肝臟合成四種凝血因子(活性凝血因子Ⅱ(凝血酶原)、凝血因子Ⅶ、凝血因子Ⅺ和凝血因子Ⅹ)所必需物質(zhì),如果缺乏維生素K1,則肝臟合成的上述四種凝血因子為異常蛋白質(zhì)分子,它們催化凝血作用的能力大為下降。人們已知維生素K是谷氨酸γ羧化反應(yīng)的輔因子。缺乏維生素 K則上述凝血因子的γ-羧化不能進(jìn)行,此外,血中這幾種凝血因子減少,會出現(xiàn)凝血遲緩和出血病癥。此外,人們公認(rèn)維生素K溶于線粒體膜的類脂中,起著電子轉(zhuǎn)移作用,維生素 K可增加腸道蠕動和分泌功能,缺乏維生素K時平滑肌張力及收縮減弱,它還可影響一些激素的代謝。如延緩糖皮質(zhì)激素在肝中的分解,同時具有類似氫化可的松作用,長期注射維生素K可增加甲狀腺的內(nèi)分泌活性等。
維生素K可劃分為二大類,均為2-甲基-1,4-萘醌的衍生物,一類是脂溶性維生素,即從綠色植物(如苜蓿、菠菜等綠葉植物等)中提取的維生素K1和從微生物中提取的維生素 K2,人體腸道細(xì)菌(如大腸桿菌)也可合成維生素K2。維生素K1是黃色油狀物,K2是淡黃色結(jié)晶,均有耐熱性,但易受紫外線照射而破壞,故要避光保存。另一類是水溶性的維生素,由人工合成即維生素K3和K4。最重要的是維生素K1和K2。
維生素K呈油狀液體或固體,不溶于水,能溶于油脂及醚等有機(jī)溶劑,化學(xué)性質(zhì)較穩(wěn)定,能耐熱耐酸,但易被堿和紫外線分解。人體需要量少、新生兒卻極易缺乏的維生素K,是促進(jìn)血液正常凝固及骨骼生長的重要維生素。深綠色蔬菜及優(yōu)酪乳是日常飲食中容易取得的維生素K補給品。人體維生素K的需要量非常少,但它卻是維護(hù)血液功能正常凝固,減少生理期大量出血,還可防止內(nèi)出血及痔瘡。經(jīng)常流鼻血的人,應(yīng)該多從天然食物中攝取維生素K。
Phylloquinone (vitamin K1) and Menaquinones (vitamin K2) are the two naturally occurring forms of vitamin K. Phylloquionone is the major dietary source of vitamin K and is found at highest concentrations in green leafy vegetables. Vitamin K2 (menaquinone) is found in small amounts in chicken, butter, egg yolks, cheese and fermented soyabeans. Vitamin K1 and vitamin K2 are required for the γ-glutamyl carboxylation of all vitamin K-dependent proteins. Vitamin K has important actions in the nervous system. Vitamin K contributes to the biological activation of proteins Gas6 and protein S, ligands for the receptor tyrosine kinases of the TAM family (Tyro3, Axl, and Mer). In brain, vitamin K also participates in the synthesis of sphingolipids, an important class of lipids present in high concentrations in brain cell membranes.
Vitamin K is well-known for its function in blood coagulation. Several human studies report the beneficial role of vitamin K supplementation in improving insulin sensitivity and glucose tolerance, preventing insulin resistance, and reducing the risk of type 2 diabetes. The adequate intake for vitamin K has been proposed to be 90 μg/day for women and 120 μg/day for men. Vitamin K deficiency results in an increase in undercarboxylated osteocalcin, a protein with low biological activity. Several studies have demonstrated that low dietary vitamin K intake is associated with low bone mineral density or increased fractures. Additionally, vitamin K supplementation has been shown to reduce undercarboxylated osteocalcin and improve the bone turnover profile.